Description
The FDA / Center for Drug Evaluation and Research (CDER) / Office of Pharmaceutical Quality Research (OPQR) requires to obtain an advanced lyophilization process modeling and simulation platform to study emerging pharmaceutical manufacturing technologies. Please review the attached Intent to Sole Source FDA-75F40126Q00155 document for more information.
Classification
Place of Performance
Contracting Office
Contacts
Attachments (1)